Business
Qilian International Holding Group Limited Donates Pharmaceutical Products Gan Di Xin® Worth RMB500,000 and Other Materials to Help Fight Local COVID-19 Epidemic
JIUQUAN, China, Nov. 1, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and
About this update from Bgm Group Ltd.
[{"type":"text","content":"JIUQUAN, China, Nov. 1, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the \"Company\"), a China-based pharmaceutical and chemical products manufacturer, announced that recently, through its subsidiary Gansu Qilianshan Pharmaceutical Co., Ltd. (\"Gansu QLS\"), the Company donated Gan Di Xin®, its self-developed antitussive and expectorant medicine, and 75% alcohol disinfectant, with an aggregate value of more than RMB500,000 to the government of Suzhou District, Jiuquan City to help control the spread of local COVID-19 epidemic newly reported in October.\nSince October 2021, new cases of COVID-19 infection have been reported in several provinces in China, including Inner Mongolia, Shaanxi, Gansu and Ningxia. The Company took immediate actions and donated its innovative products, Gan Di Xin® and 75% alcohol disinfectant to the government of Suzhou District, Jiuquan City, to assist local governments in controlling the spread of COVIDI-19 and take its social responsibilities to protect the health of local people.\nThe Company's product Gan Di Xin®, an enhanced type of compound licorice tablet, is an innovative antitussive and expectorant medicine made from raw licorice materials. Gan Di Xin® is independently developed by Gansu QLS protected by patents, and is a nationally well-known chemical preparation product, Gansu famous brand product, and the most influential innovative product of the Company. Gan Di Xin®'s main ingredient, glycyrrhetinic acid, could have a positive effect on the antiviral function of coronavirus, according to a research article published in Taylor & Francis.\nThe Company donated RMB2 million worth of drugs to the affected areas in Hubei back in the early days of the COVID-19 outbreak. In February 2020, just few months after the COVID-19 outbreak started, the Company donated a large amount of Gan Di Xin® to the hardest-hit areas in Hubei such as Huanggang, Xiaogan and Yingcheng to help local hospitals treat infected people.\nMr. Zhanchang Xin, Chairman and CEO of the Company, commented, \"The global COVID-19 pandemic is still ongoing and spreading rapidly. As a pharmaceutical company, we take the responsibility to help fight the local epidemic and protect the public health.\"\nAbout Qilian International Holding Group Limited\nQilian International Holding Group Limited, headquart...